Radiesse® Voice
  
 
im a doctor

RADIESSE Voice is an injectable implant containing synthetic Calcium Hydroxylapatite (CaHA) microspheres, which have a diameter range of 25 to 45 µm, suspended in an aqueous gel carrier. These consistently shaped and sized particles have proven safe and biocompatible while allowing gradual tissue in growth for a long lasting augmentation shown to be effective up to 12-24 months.

RADIESSE Voice Gel is an injectable implant containing synthetically derived polymers, and no CaHA microspheres, suitable for 1-2 month, short-term vocal fold augmentation, in patients where reversible nerve damage is suspected, or in patients wishing a short term augmentation before making a decision to have a long term augmentation done with RADIESSE Voice.


  • Paralysis, complete nerve damage:
    RADIESSE Voice
  • Paresis, partial/temporary nerve damage:
    RADIESSE Voice Gel
  • Presbylarynx
  • Unilateral or bilateral

Important RADIESSE® VOICE and RADIESSE® Voice Gel Treatment Considerations
RADIESSE® Voice and RADIESSE® Voice Gel are FDA-cleared for vocal fold augmentation and vocal fold insufficiency associated with serious aspiration disorders. After injection, patients may experience transient throat soreness, bruising, swelling, or other local side effects. More rare side effects may include over-injection or under-injection that may require repeated intervention, and as with any injection there may be a risk of infection.